Browsing by Author "Muir, Andrew J"
Now showing items 1-8 of 8
-
A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III.
Hijazi, Ghada; Paschall, Anna; Young, Sarah P; Smith, Brian; Case, Laura E; Boggs, Tracy; Amarasekara, Sathya; ... (13 authors) (Molecular genetics and metabolism reports, 2021-12)<h4>Introduction</h4>A deficiency of glycogen debrancher enzyme in patients with glycogen storage disease type III (GSD III) manifests with hepatic, cardiac, and muscle involvement in the most common subtype (type a), or ... -
An integrated alcohol abuse and medical treatment model for patients with hepatitis C.
Proeschold-Bell, Rae Jean; Patkar, Ashwin A; Naggie, Susanna; Coward, Lesleyjill; Mannelli, Paolo; Yao, Jia; Bixby, Patricia; ... (8 authors) (Dig Dis Sci, 2012-04)BACKGROUND: Patients with chronic hepatitis C virus (HCV) infection have high rates of alcohol consumption, which is associated with progression of fibrosis and lower response rates to HCV treatment. AIMS: This prospective ... -
Antiretroviral Effects on Host Lipoproteins Are Associated With Changes in Hepatitis C Virus (HCV) RNA Levels in Human Immunodeficiency Virus/HCV Coinfected Individuals.
Naggie, Susanna; Patel, Keyur; Yang, Lan-Yan; Chow, Shein-Chung; Johnson, Victoria; Guyton, John R; Muir, Andrew J; ... (9 authors) (Open forum infectious diseases, 2015-04)We evaluated the impact of antiretroviral-induced dyslipidemia on hepatitis C virus (HCV) biogenesis in human immunodeficiency virus (HIV)/HCV coinfected patients. This study used serum samples from antiretroviral-naive ... -
Direct-Acting Antivirals Improve Access to Care and Cure for Patients With HIV and Chronic HCV Infection.
Collins, Lauren F; Chan, Austin; Zheng, Jiayin; Chow, Shein-Chung; Wilder, Julius M; Muir, Andrew J; Naggie, Susanna (Open Forum Infect Dis, 2018-01)Background: Direct-acting antivirals (DAA) as curative therapy for hepatitis C virus (HCV) infection offer >95% sustained virologic response (SVR), including in patients with human immunodeficiency virus (HIV) infection. ... -
In Memoriam: Dawn Tranchino Provenzale, MD, MS (August 18, 1955-April 20, 2021).
Dominitz, Jason A; Fisher, Deborah A; Garman, Katherine S; Hunt, Christine M; Lieberman, David; Muir, Andrew J; Onken, Jane E; ... (10 authors) (Gastroenterology, 2021-12-22) -
Role of patient factors, preferences, and distrust in health care and access to liver transplantation and organ donation.
Wilder, Julius M; Oloruntoba, Omobonike O; Muir, Andrew J; Moylan, Cynthia A (Liver Transpl, 2016-07)Despite major improvements in access to liver transplantation (LT), disparities remain. Little is known about how distrust in medical care, patient preferences, and the origins shaping those preferences contribute to differences ... -
Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.
Wilder, Julius M; Jeffers, Lennox J; Ravendhran, Natarajan; Shiffman, Mitchell L; Poulos, John; Sulkowski, Mark S; Gitlin, Norman; ... (17 authors) (Hepatology, 2016-02)UNLABELLED: Black patients chronically infected with genotype 1 hepatitis C virus (HCV) have historically had lower rates of response to interferon-based treatment than patients of other races. In the phase 3 ION program, ... -
Strategies for treating chronic HCV infection in patients with cirrhosis: latest evidence and clinical outcomes.
Wilder, Julius M; Muir, Andrew J (Ther Adv Chronic Dis, 2015-11)The burden of chronic hepatitis C virus (HCV) infection is significant and growing. HCV is considered one of the leading causes of liver disease worldwide and the leading cause of liver transplantation globally. While those ...